Connected Drug Delivery Devices Market Size, Share, Demand and

IMARC Group, a leading market research firm, recently released a report titled “Connected Drug Delivery Devices Market Report by Product (Connected Sensors, Integrated Connected Devices), End User (Hospitals & Healthcare Providers, Home Care), Technology (Bluetooth , NFC, and Others) and Region 2024-2032. The study provides a detailed analysis of the industry including Connected Drug Delivery Devices market trends, volume, share, and growth forecast. The report also includes competitive and regional analysis and highlights the latest developments in the market.

The global connected drug delivery device market size reached USD 864.4 million in 2023. IMARC Group expects the market to reach USD 6,879.9 million by 2032, growing at a CAGR of 25.1% during 2024–2032.

Request to receive a sample report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample

Factors influencing the growth of the connected drug delivery device industry:

Increasing incidence of chronic diseases:

The increasing prevalence of chronic diseases such as diabetes, asthma and cardiovascular diseases is significantly increasing the demand for connected drug delivery devices. These chronic conditions require continuous medication and adherence to treatment regimens, which can be challenging for patients. Connected medication delivery devices such as smart inhalers, insulin pens, and auto-injectors provide real-time monitoring and reminders to ensure patients are adhering to prescribed therapies. Better adherence increases treatment effectiveness and helps reduce hospitalizations and health care costs. The ability of these devices to track and record medication use data enables healthcare providers to make informed decisions and adjust treatment plans as needed, driving market growth.

Advances in digital health technologies:

The integration of wireless connectivity, sensors and mobile applications with drug delivery devices has changed the way patients and healthcare providers interact with medication management. These technological advances enable seamless data transmission between devices and healthcare systems, facilitating remote monitoring and telemedicine. For example, Bluetooth-equipped smart inhalers can connect to mobile apps that track usage patterns, display reminders and generate reports for healthcare providers. The emergence of the Internet of Things (IoT) and artificial intelligence (AI) is further expanding the capabilities of these devices, enabling predictive analytics and personalized medicine, driving market growth.

Increasing emphasis on patient-centered care:

Modern healthcare is increasingly focused on empowering patients to take an active role in managing their health. Connected drug delivery devices fit into this approach, providing patients with the tools to better understand and control their treatment regimens. These devices offer user-friendly interfaces, personalized feedback and educational resources to increase patient engagement and self-management. The ability to share data with health care providers in real time also fosters a collaborative approach to care in which patients and providers can work together to optimize treatment. Additionally, connected drug delivery devices can improve patient satisfaction by reducing the complexity of medication management and minimizing the burden of chronic disease management, contributing to market expansion.

Talk to an analyst: https://www.imarcgroup.com/request?type=report&id=3738&flag=C

Segmentation of the Connected Drug Delivery Devices Market Report:

By product:

• Connected sensors
• Integrated connected devices

On the basis of product, the market is segmented into connected sensors and integrated connected devices.

By end user:

• Hospitals and healthcare providers
• Home care

Based on the end user, the market is segmented into hospitals, healthcare providers and home care.

By technology

• Bluetooth
•NFC
• Others

Based on technology, the market is segmented into Bluetooth, NFC and others.

Regional information:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Based on region, the market is segmented into North America (United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, United Kingdom, Italy, Spain , Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.

Global Market Trends for Connected Drug Delivery Devices:

Increasing regulatory requirements for precision measurement of fluids in the pharmaceutical and food and beverage (F&B) industries, ensuring product quality and safety, along with increasing emphasis on non-destructive testing and maintenance practices in critical infrastructure sectors, are helping to grow the market. At the same time, the growing adoption of smart water management systems in urban infrastructure projects, which require accurate and efficient flow measurement solutions to optimize water use and reduce waste, is supporting the growing demand for advanced measurement technologies. Additionally, there is an increasing demand for precise flow measurement in renewable energy applications such as hydropower and geothermal power plants, where accurate monitoring of fluid dynamics is crucial for optimizing energy production and operational efficiency, enhancing market growth.

Top Companies in the Connected Drug Delivery Devices Industry:

• Adherium Ltd.
• BioCorp Production
• Cohero Health Inc. (AptarGroup Inc.)
• Elcam Medical ACS. Sp. z o. o
• Findair Sp. Zoo
• Merck KGaA
• Phillips Medisize (Molex LLC)
• Propeller condition (Resmed Inc.)
• Teva Pharmaceutical Industries Ltd.
• West Pharmaceutical Services Inc.

The most important information included in the report:

• Market performance (2018-2023)
• Market prospects (2024-2032)
• Market trends
• Market factors and success factors
• Impact of COVID-19
• Value chain analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently covered by the report, we will make it available as part of the customization.

About us:

IMARC Group is a leading market research company offering management strategy and market research worldwide. We work with clients across all sectors and regions to identify their highest-value opportunities, address their most important challenges and transform their businesses.

IMARC’s information products cover the most important market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the forefront of the company’s expertise.

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
E-mail: [email protected]
Telephone No.:(D) +91 120 433 0800
United States: +1-631-791-1145

IMARC Group is a leading market research company offering management strategy and market research worldwide. We work with clients across all sectors and regions to identify their highest-value opportunities, address their most important challenges and transform their businesses.

IMARC’s information products cover the most important market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the forefront of the company’s expertise.

This release was published on openPR.